ArticleFrontiers in pharmacology2022

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity.

Si-Yu Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.